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Toledo b, and Riad N. Younesa
Extra-adrenal paragangliomas are very uncommon
tumors arising from neuroectodermal-derived paraganglion
tissue.1 These tumors are usually located along the vascu-
lar tree, especially near the carotid body, the
jugulotympanic body, or the mediastinal vessels.2
While these low-grade tumors often occur in the supe-
rior or inferior para-aortic regions, there are reports of their
presence in virtually every organ. However, the existence
of paragangliomas as primary tumors of the lung remains
controversial. Many cases reported as primary pulmonary
paragangliomas (PPP) are not altogether convincing. This
is because completely unrelated lesions, currently classi-
fied as meningoendothelial nodules, were previously known
as chemodectomas and were classified as paragangliomas
in the 1981 World Health Organization classification of
tumors.1
Both solitary and diffuse PPP have been encountered
in the lungs. Until recently they were classified as either
pulmonary chemodectomas or carotid-body-like tumors of
the lung.4 The solitary form of this tumor is rare.5
Heppleston first described PPP in 1958, and according to
Aubertine, until 2004, only 23 cases were confirmed.1
We present a case of PPP with histologic and immuno-
histochemical findings and a critical review of the literature.
A 60-year-old woman with no previous symptoms pre-
sented to the Department of Thoracic Surgery of the Hos-
pital do Câncer AC Camargo, where a routine chest x-ray
revealed a pulmonary nodule. She was in good health and
had quit cigarette smoking 10 years earlier. The clinical
examination showed no remarkable findings, and the labo-
ratory tests were normal. Computed tomography of the
chest showed in the right lower lobe a nodule 12.0 mm in
diameter with a lobulated margin (Figure 1). No signifi-
cant alterations were observed in other organs. The patient
underwent a right thoracotomy, and a segmentectomy was
necessary for complete resection. Frozen section evalua-
tion showed an irregular nodule with a smooth surface and
ground glass opacity, consistent with a benign lesion. The
postoperative course was uneventful, and she was dis-
charged on the fourth day after surgery in good clinical con-
dition.
The final pathology report showed a nodular, well cir-
cumscribed, lobulated tumor located in the bronchial sub-
mucosa. The tumor was surrounded by bronchial cartilage
with no infiltration. Histologically, the tumor was
hypercellular, arranged in an anastomosing trabecular or
nesting pattern (zellballen) within an arcuate vascular net-
work (Figure 2). It was composed of nests of ovoid or po-
lygonal cells, with abundant acidophilic cytoplasm and
round-to-oval and occasional spindle nuclei with speckled
chromatin. Conspicuous nucleoli were occasionally visible.
Mitosis was absent. Nests of cells were surrounded by
stellate spindle sustentacular cells and thin-walled vascu-
lar channels. Chief cells were intensely positive for neu-
roendocrine markers such as chromogranin A (Figure 3),
synaptophysin, and neuron-specific enolase (NSE) (Figures
4 and 5 ). Sustentacular cells were positive for S-100 pro-
tein (Figure 6), but negative for cytokeratins (AE1/AE3,
CK7, CK20, CK8). Expression of thyroid transcription fac-
tor-1 was not observed. All these findings were consistent
with pulmonary paraganglioma.
Six months of follow-up produced no evidence of re-
currence, and no further treatment was required.
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After the first case of a solitary PPP reported by
Heppleston, at least 23 cases have been described. This case
report contributes a well-documented example of PPP. The
presented neoplasm meets the Armed Forces Institute of
Pathology’s suggested morphologic criteria for the diagno-
sis of paraganglioma. These include a diffuse zellballen
pattern throughout the tumor, the absence of classic carci-
noid tumor architecture, the presence of cytoplasmic
vacuoles distinctive of paragangliomas, a negative immu-
nohistochemical staining for cytokeratin, and the exclusion
Figure 1 - Pulmonary nodule (RLL)
Figure 2 - Zellballen pattern (40x)
Figure 3 - Chromogranin expression (40x) Figure 6 - S 100 protein expression (40x)
Figure 5 - Neuron-specific enolase expression (40x)
Figure 4 - Synaptophysin expression (40x)
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of an extrapulmonary paraganglioma or pheochromocy-
toma.6
Primary pulmonary paraganglioma of the lung is dis-
tinct from the so-called multiple chemodectoma in its site
of origin, growth pattern, and ultrastructure. The presence
of neurosecretory granules does not permit a distinction
between paraganglioma and bronchial carcinoid tumors.1,5
Some previous case reports based the diagnosis on the pres-
ence of sustentacular cells, because their presence was
originally thought to be a specific diagnostic feature of
paragangliomas. However, many studies have reported S-
100 protein positive stellate cells resembling sustentacular
cells in bronchial carcinoids in up to 76% of cases. While
there is some ongoing debate as to whether these S-100
protein positive cells are mesenchymal or neuroendocrine
in origin, it is generally agreed that they are not a distin-
guishing feature of paragangliomas. As the Armed Forces
Institute of Pathology criteria suggest, cytokeratin can aid
in the distinction between a PPP and a carcinoid, but is not
absolutely diagnostic. As expected, nearly 100% of bron-
chial carcinoids, despite their degree of differentiation, will
be positive for cytokeratins. Some previous cases had posi-
tive staining for cytokeratin; therefore, they are more con-
sistent with a carcinoid tumor.8 The most recent World
Health Organization classification has corrected the con-
fusion by defining the meningoendothelial nodule and para-
ganglioma as entirely separate entities. In addition, the
morphologically distinct gangliocytic paraganglioma should
not be confused with a paraganglioma.
The grouping of tumors of the paraganglion system,
with a subclassification based upon the specific paragan-
glionic tissue (branchiomeric, intravagal, aortico-
sympathetic, or visceral autonomic), serves the useful pur-
pose of combining tumors having a similar anatomic dis-
tribution, innervation, and microscopic structure. A further
division of paraganglion tumors into functional or nonfunc-
tional provides a clinically valuable distinction.4,6 Two
forms of pulmonary paraganglia have been described. The
first consists of multiple, minute pulmonary paraganglio-
mas found in approximately 3% of the normal population
at autopsy.7 Some authors suggest that these minute lesions
represent ischemic stimulation of pre-existing paragangli-
onic cells resulting from pulmonary vascular obstruction.
Association with pulmonary thromboemboli has been de-
scribed in the adjacent blood vessel.1–4 Clinical symptoms
and malignant activity have not been noted. The second
form of pulmonary paraganglioma is a large solid tumor
in the lung parenchyma, which was first reported in 1958
by Heppleston. As reported by Aron in 1977, all the tumors
were removed surgically, with most of them located subp-
leurally.4 There was no evidence of local invasion of any
other structure except in 1 case, in which the tumor had
invaded the brachial plexus. Also important is the fact that
in the lung, metastatic paraganglioma is more common than
PPP.3
Until 1995, 21 cases had been reported and reviewed
by Skot et al.3 The majority of these patients were asymp-
tomatic, but 3 patients had hypertension, perhaps for other
reasons. Seventeen of the tumors were located in the right
lung and 5 in the left lung. Eighteen tumors were grossly
and histologically benign. One tumor showed invasive
growth and penetration of the capsule but no other signs
of malignancy. In 1 case, which was the largest reported
tumor, there was local invasion of the apex of the pleural
cavity and of the brachial plexus, with some tumor tissue
attached to the brachial plexus that was left behind at the
operation.4 Areas of hemorrhage and necrosis in this tumor
were described, but no lymph node metastases were found.
Our case also showed no necrosis or mitosis, and no lymph
nodes were found during surgery. Malignant PPP is dis-
tinctly uncommon, with only 1 case having been reported
in a 49-year-old woman.2 She had lymph node metastases,
but there was no evidence of distant metastases or any
extrapulmonary involvement.
The distinction between benign and malignant paragan-
glioma is based on a low metastatic rate with a biologic
behavior similar to that of a typical carcinoid. The differ-
ential diagnosis may be difficult on a purely morphologi-
cal basis. In several studies, attempts have been made to
distinguish between benign and malignant cases by immu-
nohistochemical investigations. Some authors have found
a reduced number of the S-100 protein-immunoreactive sus-
tentacular cells 4,8 but these results were not confirmed in
other studies. It seems that decreased immunoreactivity
against NSE is found in malignant paragangliomas.
With the present experience, the acceptable treatment
appears to vary from enucleation, wedge resection, and seg-
mentectomy if the tumor is small, and lobectomy if the
tumor is large or location permits. As in our case, surgical
treatment seems to be sufficient, and extensive resections
are not warranted.3,4
Our findings confirm the existence of PPP and show the
importance of the differential diagnosis between paragan-
gliomas and lung tumors such as typical carcinoids.
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